1. 1. Aldridge, K. E., Henderberg, A. and Sanders, C. V. 1989. Lomefloxacin (SC 47111 or NY-198), a new diofluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. Suppl. 12: 1–6.
2. 2. Erjongmanee, S., Kasetsuwan, N., Phusitphoykai, N., Puangsricharern, V. and Pariyakanok, L. 2004. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis. J. Med. Assoc. Thai. 87: S83–90.
3. 3. Fukuda, M. and Sasaki, K. 1986. Penetration of topically administered ofloxacin into ocular tissues. Nippon Ganka Kiyo 37: 823–828 (in Japanese).
4. 4. Fukuda, S., Mikitani, M., Ueda, T., Inatomi, M., Koide, R., Kurata, N., Uchida, E., Yasuhara, H., Uchida, N., Kanda, Y., Yamazaki, Y., Kiuchi, Y. and Oguchi, K. 1995. Application of microdialysis for pharmacokinetic study in rabbit anterior chamber. J. Jpn. Ophthalmol. Soc. 99: 400–405(in Japanese).
5. 5. Giuliano, E. A. 2011. Equine ocular adnexal and nasolacrimal disease. pp. 133–180. In: Equine Ophthalmology, 2nd ed. (Gilger, B. C. ed.), Elsevier, Inc., Maryland Heights.